Atreca, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | −$97.2M | −$109.3M | −$86.3M | −$67.5M | −$37.9M |
| Total assets | $155.0M | $200.1M | $272.1M | $195.7M | $121.7M |
| Total liabilities | $76.6M | $45.1M | $30.0M | $8.8M | $5.0M |
| Equity | $78.4M | $154.9M | $242.1M | $187.0M | −$93.0M |
| EPS (diluted) | $-2.52 | $-2.95 | $-2.70 | — | — |
| Shares out. | 38.6M | 37.0M | 31.9M | — | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- —
- Net margin
- —
- Return on equity
- −123.9%
- Return on assets
- −62.7%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 49.4%
- Debt / equity
- 0.98×
- Book value / share
- $2.03
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Accruals / assets
- −10.6%clean
- Piotroski F-Score
- 1/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 warning● 2 good- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Orwin John AOfficer — PRESIDENT & CEO | Apr 11, 2024 | Buy | 1 | $0.01 |
| Serafini TitoDirector | Apr 1, 2024 | Sell | 20,788 | $0.07 |
| Orwin John AOfficer — PRESIDENT & CEO | Sep 1, 2023 | Sell | 22,951 | $0.37 |
| Serafini TitoDirector | Sep 1, 2023 | Sell | 8,393 | $0.37 |
| Courtney PhillipsOfficer — GENERAL COUNSEL & SECRETARY | Sep 1, 2023 | Sell | 7,061 | $0.37 |
| Baker Bros. Advisors Lp | Oct 19, 2023 | Sell | 22,837 | $0.40 |
| Serafini TitoOfficer — Chief Strategy Officer | Aug 2, 2023 | Sell | 5,487 | $0.95 |
| Cross HerbOfficer — Chief Financial Officer | Aug 2, 2023 | Sell | 5,487 | $0.95 |
| Gould Stephen EOfficer — Chief Scientific Officer | Aug 2, 2023 | Sell | 4,076 | $0.95 |
| Courtney PhillipsOfficer — General Counsel & Secretary | Aug 2, 2023 | Sell | 4,076 | $0.95 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeMar 11, 2024
- Director / officer changeFeb 6, 2024
- Entered a material agreement · Director / officer change · Regulation FD disclosure · Other material eventDec 26, 2023
- Results of operationsNov 14, 2023
- Terminated a material agreement · Director / officer change · Regulation FD disclosureSep 21, 2023
- Delisting / listing-standard noticeSep 14, 2023
- Results of operations · Costs from exit or disposalAug 10, 2023
- Shareholder voteJun 15, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.